Zobrazeno 1 - 10 of 143 pro vyhledávání: '"CONTASTA I."'
1
Immunological pathways in diagnosis, treatment, cure and prevention of human disease: 'Gender-Specific Cytokine Pathways, Targets and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer'
Autor: PELLEGRINI P, CONTASTA I, DEL BEATO T, CICCONE F, AND BERGHELLA AM.
Publikováno v: Clinical and developmental immunology (Online) (2012). doi:10.1155/2011/819724.
info:cnr-pdr/source/autori:PELLEGRINI P, CONTASTA I, DEL BEATO T, CICCONE F, AND BERGHELLA AM./titolo:Immunological pathways in diagnosis, treatment, cure and prevention of human disease: "Gender-Specific Cytokine Pathways, Targets and Biomarkers for the Switch from Health to Adenoma and Colorectal Cancer"/doi:10.1155%2F2011%2F819724./rivista:Clinical and developmental immunology (Online)/anno:2012/pagina_da:/pagina_a:/intervallo_pagine:/volume
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::b897e9af51b535f96705fd30c0871740
http://globalmedicaldiscovery.com/key-scientific-articles/gender-specific-cytokine-pathways-targets-and-biomarkers-for-the-switch-from-health-to-adenoma-and-colorectal-cancer/
Zobrazit plný text záznamu
2
The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy
Autor: Berghella AM, Pellegrini P, Del Beato T, Ciccone F, Contasta I
Publikováno v: Cancer immunology and immunotherapy 60 (2011): 1373–1381.
info:cnr-pdr/source/autori:Berghella AM, Pellegrini P, Del Beato T, Ciccone F, Contasta I/titolo:The potential role of thioredoxin 1 and CD30 systems as multiple pathway targets and biomarkers in tumor therapy/doi:/rivista:Cancer immunology and immunotherapy/anno:2011/pagina_da:1373/pagina_a:1381/intervallo_pagine:1373–1381/volume:60
Our progress in understanding pathological disease mechanisms has led to the identification of biomarkers that have had a considerable impact on clinical practice. It is hoped that the move from generalized to stratified approaches, with the grouping
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::0ec153c1d5563efe44da3cf534dec881
http://www.cnr.it/prodotto/i/59245
Zobrazit plný text záznamu
3
Classification of cancer stage using the immune system
Autor: Pellegrini P, Contasta I, Berghella AM, Del Beato T, Adorno D.
Publikováno v: Methods of Cancer Diagnosis, Therapy and Prognosis. General Overviews, Head and Neck Cancer and Thyroid Cancer, edited by M.A. Hayat, pp. 195–213. Berlin Heidelberg: Springer-Verlag, 2010
info:cnr-pdr/source/autori:Pellegrini P; Contasta I; Berghella AM; Del Beato T; and Adorno D./titolo:Classification of cancer stage using the immune system./titolo_volume:Methods of Cancer Diagnosis, Therapy and Prognosis. General Overviews, Head and Neck Cancer and Thyroid Cancer/curatori_volume:M.A. Hayat/editore: /anno:2010
In cancer research, as Jarnicki et al. (2006) and Benzoni et al. (2007) have shown, surgery continues to be the main treatment option though irradiation and chemotherapy have become increasingly important and may, in certain cases, improve the cure r
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::8e4eb663daa340fe876d07e53005c7c8
http://www.cnr.it/prodotto/i/132261
Zobrazit plný text záznamu
5
Classification of cancer stage using the immune system
Autor: PELLEGRINI P., CONTASTA I., BERGHELLA A.M., DEL BEATO T. AND ADORNO D.
Publikováno v: info:cnr-pdr/source/autori:PELLEGRINI P., CONTASTA I., BERGHELLA A.M., DEL BEATO T. AND ADORNO D./titolo:Classification of cancer stage using the immune system./titolo_volume:/curatori_volume:/editore:/anno:2008
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::5d9979b2a8a8cd23d8ee5d898fb6342f
http://www.cnr.it/prodotto/i/132259
Zobrazit plný text záznamu
6
CD30 molecule, the immune system and multiple sclerosis
Autor: BERGHELLA AM, PELLEGRINI P, CONTASTA I, CAROLEI A, ADORNO D
Publikováno v: Multiple Sclerosis Research Progress, edited by Hanna Schwarz; Lena Walter, pp. 83–121. Hauppauge: Nova Science Publishers, 2008
info:cnr-pdr/source/autori:BERGHELLA AM; PELLEGRINI P; CONTASTA I; CAROLEI A; ADORNO D/titolo:CD30 Molecule, The Immune System and Multiple Sclerosis./titolo_volume:Multiple Sclerosis Research Progress/curatori_volume:Hanna Schwarz; Lena Walter/editore: /anno:2008
Objectives: on the basis of our own and other research on the CD30 molecule, we hypothesized that CD30 may be the unknown molecule involved in the cell contact-dependent suppression of T regulatory cells (Trs) by regulatory dendritic cells (rDCs). Tr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::9606e6b9b1e9d60007ee74aec794fde8
http://hdl.handle.net/11697/25901
Zobrazit plný text záznamu
7
Immunological mechanisms in the establishment and progression of colon caner
Autor: Pellegrini P, Del Beato T, Adorno D, Contasta I, Berghella AM
Publikováno v: Trends in Cancer Research 1 (2005): 29–58.
info:cnr-pdr/source/autori:Pellegrini P, Del Beato T, Adorno D, Contasta I, Berghella AM/titolo:Immunological mechanisms in the establishment and progression of colon caner/doi:/rivista:Trends in Cancer Research/anno:2005/pagina_da:29/pagina_a:58/intervallo_pagine:29–58/volume:1
The lymphokines produced by TH1 and TH2 subsets of CD4+ T helper (TH) cells are critical to the effectiveness of the immune response. In vivo and in vitro studies have demonstrated that environmental cytokines determine the development of naive T cel
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::54b4683b6672948d4f4fdd786e1f0b1a
http://www.researchtrends.net/tia/title_issue.asp?id=57&in=0&vn=1
Zobrazit plný text záznamu
8
Immunological mechanisms in the establishment and progression of colon cancer
Autor: BERGHELLA AM, PELLEGRINI P, CONTASTA I, DEL BEATO T, ADORNO D
Publikováno v: Trends in Cancer Research 1 (2005).
info:cnr-pdr/source/autori:BERGHELLA AM; PELLEGRINI P; CONTASTA I; DEL BEATO T; ADORNO D/titolo:Immunological mechanisms in the establishment and progression of colon cancer./doi:/rivista:Trends in Cancer Research/anno:2005/pagina_da:/pagina_a:/intervallo_pagine:/volume:1
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::fb39fc55f33b4030f7a54564a96ab16c
https://publications.cnr.it/doc/59428
Zobrazit plný text záznamu
9
Prognostic indices for the early classification of colon cancer stage
Autor: PELLEGRINI P, BERGHELLA AM, CONTASTA I, DEL BEATO T, ADORNO D
Publikováno v: Trends in Cancer Research 1 (2005): 1–27.
info:cnr-pdr/source/autori:Berghella AM, Adorno D, Contasta I, Pellegrini P, Del Beato T/titolo:Prognostic indices for the early classification of colon cancer stage/doi:/rivista:Trends in Cancer Research/anno:2005/pagina_da:1/pagina_a:27/intervallo_pagine:1–27/volume:1
Trends in Cancer Research 1 (2005).
info:cnr-pdr/source/autori:PELLEGRINI P; BERGHELLA AM; CONTASTA I; DEL BEATO T; ADORNO D/titolo:Prognostic indices for the early classification of colon cancer stage./doi:/rivista:Trends in Cancer Research/anno:2005/pagina_da:/pagina_a:/intervallo_pagine:/volume:1
One of the most important factors in determining patient prognosis in cancer, is the extent to which the disease has spread (stage). The stage of the disease dictates the therapy. Hence any early screening tests that can contribute to the classificat
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::764d680fd90d4a7bec1365fb854fc837
http://www.cnr.it/prodotto/i/339915
Zobrazit plný text záznamu
10
CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance
Autor: BERGHELLA AM, PELLEGRINI P, CONTASTA I, CAROLEI A, ADORNO D
Publikováno v: New Research on Immunology, edited by Barbara A. Veskler, pp. 201–240. Hauppauge: Nova Science Publishers, 2005
info:cnr-pdr/source/autori:BERGHELLA AM; PELLEGRINI P; CONTASTA I; CAROLEI A*; ADORNO D/titolo:CD30 Molecule, the Immune System and Multiple Sclerosis. CD30 the still unknown molecule involved in the cell contact-dependent suppression of T cells by dendritic cells, which mediated signals responsible for maintainig the physiological balance between: dendritic and T regulatory cells, the immune responses and central and peripheral tolerance./titolo_volume:New Research on Immunology/curatori_volume:Barbara A. Veskler/editore: /anno:2005
Objectives: on the basis of our own and other research on the CD30 molecule, we hypothesized that CD30 may be the unknown molecule involved in the cell contact-dependent suppression of T regulatory cells (Trs) by regulatory dendritic cells (rDCs). Tr
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=cnr_________::b240d0346adfdab14dc14e50af869f9c
https://publications.cnr.it/doc/175713
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje